News
Wanbande Group expands into Africa's health industry by acquiring South African companies T-Mark and Elite.
Date:
01 Mar,2021
On June 10, Wanbangde Group officially acquired two prominent South African medical device companies, T-Med and Elite, during a formal handover ceremony and press conference held at the Gallagher Exhibition Centre in Johannesburg, South Africa. The acquisition marks the establishment of Anlan Medical (China) Co., Ltd., a company invested in by Wanbangde Group in South Africa. The total transaction value of the deal reached 264 million Rand, equivalent to over 120 million RMB. Attendees at the event included Counselor Yu Yong from the Chinese Embassy in South Africa, Chairman Zhao Shouming, Co-Chairman Gao Jian of Anlan Securities South Africa, John O’Toole, Managing Director of Elite Medical Company in South Africa, William Skyes, Managing Director of T-Med, and other industry leaders from South Africa’s medical sector.
Both medical device companies involved in this acquisition are globally oriented, international enterprises. Among them, Ailit is a manufacturer specializing in implantable artificial orthopedic products, boasting strong R&D capabilities and offering products that can compete on par with those of multinational giants like Johnson & Johnson and Medtronic. Meanwhile, Temak stands out as one of the leading companies capable of delivering comprehensive "turnkey" projects—ranging from medical equipment sales and engineering services to holistic hospital design, complete procurement and installation of all necessary equipment, ongoing maintenance, and even the development of hospital management systems and specialized technical training for healthcare professionals.
Guided by Wanbande Group’s strategic vision of a globalized "Greater Health Industry" initiative, the group has been actively entering the medical device sector since last year. This time, through the acquisition of equity stakes in T-Mic and Elite companies, along with investments in follow-up projects, the group is accelerating its industrial restructuring and driving a transformative upgrade of its business model. Zhao Shouming, Chairman of the Group, emphasized that this acquisition marks the beginning of Wanbande Group’s foray into Africa’s health industry. He added that these strategic moves not only address the company’s existing gaps in research and development but also position South Africa as a strategic foothold, enabling Wanbande to leverage China’s robust manufacturing capabilities and financial strength—ultimately facilitating the export of more pharmaceuticals and medical devices to underserved African markets grappling with severe shortages of healthcare resources.
To commercialize the technologies of Elite Company and Temac Company, Wanbond Group has also acquired two domestically-based enterprises specializing in medical device manufacturing. Chairman Zhao Shouming stated that building Asia’s largest orthopedic device production base is one of Wanbond Group’s key future goals. We aim to develop four major product lines within the orthopedic medical device sector—covering spinal implants, joint replacements, trauma repair solutions, and biomaterials—and will leverage our strengths in pharmaceutical and medical device R&D. This strategic move will enable us to advance hand-in-hand with the broader healthcare industry while aggressively expanding into both international and domestic markets.
The successful acquisition of two renowned healthcare companies by Wanbande Group in South Africa marks the company’s steady expansion beyond China, positioning it firmly on the global stage and officially establishing its presence as a multinational corporate group. This strategic move paves the way for the group to deepen its involvement in industries such as pharmaceuticals, hospitals, and medical devices, thereby launching its ambitious growth strategy in the broader healthcare sector.
Chairman Zhao Shouming acquires South African companies T-Mac and Elite.
Chairman Zhao Shouming Answers Questions from Reporters
Related Recommendations